Newsletter

October 24, 2022

 

Congress23 650x320 

Program Spotlight:

Gain Actionable Insights in Orlando This December

More than 200 hospital, health system and health plan executives consider artificial intelligence to be “important” (30%) or “very important” (64%) for remaining competitive, according to a recent report from Deloitte. Moreover, 85% of respondents expect their AI investments will increase during the 2022–2023 fiscal year.

With AI becoming one of the biggest areas of investment in the healthcare space, now is the time for healthcare leaders to ensure they are up to speed on this game-changing innovation. This December, executives will have an opportunity to do just that at the Orlando Cluster, Dec. 5–8. This in-person event offers a range of interactive, one- and two-day seminars that explore critical topics such as digital innovation, health law, crisis leadership, high reliability and workforce transformation. Following are some of the seminars that will be offered:

6 CEU Courses 12 CEU Courses

In addition, Quest Diagnostics, an ACHE Premier Corporate Partner, will be hosting an education session, “How to Prepare Your Health System Now for the Lab of the Future,” and a reception immediately afterward on Dec. 5 and 7.

There’s still time to register for the Orlando Cluster, but don’t delay. December will be here before you know it!

Cancer Care 300x250

Back to Top ▲


The Future of Cancer Detection—Multicancer Early Detection Testing

Multicancer early detection testing has the potential to transform cancer detection. Cancer is the second-leading cause of death in the United States. Earlier detection and treatment of cancer is critical as survival dramatically improves when cancer is diagnosed before it has spread, and treating early-stage cancer is often less costly.

Using a simple blood draw, MCED tests look for multiple cancer types. About 70% of cancers don’t have a screening standard, and fewer than 30% of diagnosed cancers are caught with routine screenings.

“Earlier detection is the best way to bend the cancer mortality curve,” says Bruce A. Meyer, MD, president of Jefferson Health.

DETECT-A was the first-ever prospective, interventional study of an MCED blood test, which found that:

  • MCED testing doubled cancer detection through screening.
  • Sixty-five percent of cancers identified by the test were in earlier stages (I-III).
  • Cancers were found in 10 organs—seven of which have no screening options.
  • Post-study surveys revealed high participant satisfaction and that MCED testing didn’t deter from standard screenings.

Exact Sciences is accelerating later-phase research of the DETECT-A assay, which will be reviewed in a randomized controlled trial to gain Food and Drug Administration approval. In addition, Congress introduced a bill to provide Medicare coverage for FDA-approved MCED tests.

MCED testing could fundamentally change cancer detection standards. However, making earlier detection routine practice will require collaboration between academia, industry, policymakers, health systems and others.

For more information on MCED and cancer care innovations, visit exactsciences.com.

Exact Sciences, an ACHE Premier Corporate Partner, provided the content above.

PINC 300x250

Back to Top ▲


ACHE Would Like Your Input on Our Strategic Plan

ACHE’s Strategic Plan leverages the organization’s role in building a leadership workforce capable of addressing the challenges facing our field now and in the future. The plan builds on the hallmarks of our commitments to integrity, lifelong learning, leadership, and diversity and inclusion, and amplifies our aspirations in service to our members, our profession and our field.

The 2022–2024 Strategic Plan focuses on ACHE’s work to advance health by leading for equity and safety, grow our professional community of leaders by leveraging our partnerships with chapters and other organizations, and help leaders reach their highest potential by deepening our engagement with members and the healthcare community.

ACHE annually examines its Strategic Plan with a continuing focus on meeting the evolving needs of our members and the healthcare field. The three-year Strategic Plan focuses on ACHE’s roles as catalyst, connector and trusted partner, and translates our ambitions in each area to specific actions we will undertake.

If you would like to provide your feedback, please take a moment to review the 2022–2024 Strategic Plan, and send us your thoughts, comments and ideas for improvement. Please direct your email response to the ACHE Executive Office at strategicplan@ache.org. The deadline for comments is Oct. 31.

IHF Dubai 300 250

Back to Top ▲


It’s Time to Recertify Your FACHE®

If you are an ACHE Fellow whose credential is set to expire in 2022, it’s time to recertify. ACHE Fellows must recertify their FACHE every three years, and they can do so in three easy steps:

  • Complete a minimum of 36 continuing education hours related to healthcare management and administration (12 hours must be ACHE Face-to-Face Education hours) OR retake and pass the Board of Governors Exam.
  • Complete four volunteer activities, including two that are community/civic-related and two related to healthcare.
  • Pay the $200 recertification fee when you submit your recertification application by the Dec. 31 deadline.

Learn more about the recertification process by visiting ache.org/FACHE and selecting the Maintain/Recertify My FACHE button from the menu. You can also check your individual progress by using the FACHE Recertification Progress tool available on My ACHE.

Additionally, if you are over the age of 60 and will retire within the next five years, you may be eligible for a one-time-only, five-year recertification waiver. For more information, please contact Customer Service at (312) 424-9400 or contact@ache.org.

Current Fellows in good standing who are retired from healthcare management may transfer to Retired Status or Life Status. Learn more about the FACHE(R) and LFACHE designations here.

Back to Top ▲


Resources to Prepare for the Board of Governors Exam

Passing the Board of Governors Exam is the final step on the path to becoming board certified in healthcare management as an ACHE Fellow. If you are working toward earning the FACHE® credential, and the Exam is the last step on your journey, we offer plenty of resources to help you prepare, including the following:

Back to Top ▲


Last Chance: IHF’s World Hospital Congress Is Two Weeks Away

Online registration ends next week for the International Hospital Federation’s 45th World Hospital Congress, scheduled to convene Nov. 9–11 in Dubai, United Arab Emirates. This unique global forum will bring together IHF members, leaders and decision-makers of hospitals, health services and healthcare organizations representing over 60 countries and territories to hear from more than 150 renowned speakers, choose from over 30 sessions, attend the IHF Awards ceremony, network and more. View the 2022 IHF Awards finalists here.

ACHE President/CEO and IHF President Deborah J. Bowen, FACHE, CAE, will chair the “IHF Women in Leadership Forum Lunch and Workshop,” and she will provide a closing speech along with Muna Tahlak, CEO of Latifa Hospital—part of the Dubai Health Authority, and IHF president designate. Peruse the preliminary program to learn more about all speakers and events.

IHF members (this includes ACHE members) may avail themselves of a special discounted rate when they use the code IHFMember2022 during registration. Discounts are also available for groups of more than three participants; please contact Anjela Bagano at anjela.bagano@index.ae for more details.

Back to Top ▲